Arkolith/Insider Trading/POAI/Form 4

Myers Robert L

Chief Financial OfficerPredictive Oncology Inc. (POAI) · full profile →Form 4 · filed Sep 24, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 23, 2021Option exercise(M)33K$1.13$38K33K
Sep 23, 2021Disposed to issuer(D)10K$1.13$12K23K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 23, 2021Option exercise(M)33K—$067K

Transaction Codes

M
Option exercise / conversion
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001179110-21-008909) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML